Biomedical subjects
Publications and source records attributed to Simon Parsons.
Two magnesium complexes of the 6-aminofulvene-2-aldimine (AFA) system bearing cyclohexyl groups on the donor nitrogen atoms have been synthesised; in the first the ligand is coordinated via the two nitrogen donors while in the second it is found to ligate magnesium via the cyclopentadienyl and the imine donors.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Luminescent lanthanide complexes have been developed, based on the assembly of bulky ligands around the lanthanide ion, to provide shell-type protection of the ion from coordinated solvent molecules. Aryl-functionalised imidodiphosphinate ligands (tpip and Metpip) provide a bidentate anionic site that leads to hexa-coordinate lanthanide complexes in which the aryl groups surround the ion. There are twelve phenyl groups around the lanthanide that act as "remote" (from the binding site) sensitisers for the metal ion. It is shown that these ligands are suitable for sensitising luminescence for all the lanthanides that emit in the visible range, namely, SmIII, EuIII, TbIII, DyIII. A "builtin" shield on the ligand is designed to provide a complete block of the approach of water to the lanthanide ion. The synthesis of the ligands and their lanthanides complexes as well as detailed photophysical studies of the complexes in solution and in the solid-state are presented.
The crystal structures of five hemiadducts of paracetamol with 1,4-dioxane, N-methylmorpholine, morpholine, N,N-dimethylpiperazine and piperazine and a related 1:1 adduct of paracetamol with 4,4'-bipyridine are described. All structures are characterized by the formation of chains of paracetamol molecules, which are linked via either OHtriplebondO=C interactions [C(9) chains in graph-set notation] or NHtriplebondO=C interactions [C(4) chains], depending on the presence or absence of substituent groups on the guest molecule. In all cases except for the morpholine and bipyridine adducts these chains are connected by hydrogen-bond interactions with the guest molecules, which reside on crystallographic inversion centres. In the bipyridine adduct this linkage also involves a pi-stacking interaction; in the morpholine adduct it is formed between the OH groups of two opposed paracetamol molecules. Most adducts (that with 4,4'-bipyridine is an exception) decompose on heating to give monoclinic paracetamol. This is the first systematic study of a series of co-crystals containing paracetamol.
The high-pressure crystal structure of phenol (C(6)H(5)OH), including the positions of the H atoms, has been determined using a combination of single-crystal X-ray diffraction techniques and ab initio density-functional calculations. It is found that at a pressure of 0.16 GPa, which is just sufficient to cause crystallization of a sample held at a temperature just above its ambient-pressure melting point (313 K), a previously unobserved monoclinic structure with P2(1) symmetry is formed. The structure is characterized by the formation of hydrogen-bonded molecular chains, and the molecules within each chain adopt a coplanar arrangement so that they are ordered in an alternating 1-1-1 sequence. Although the crystal structure of the ambient-pressure P112(1) phase is also characterized by the formation of molecular chains, the molecules adopt an approximate threefold arrangement. A series of ab initio calculations indicates that the rearrangement of the molecules from helical to coplanar results in an energy difference of only 0.162 eV molecule(-1) (15.6 kJ mole(-1)) at 0.16 GPa. The calculations also indicate that there is a slight increase in the dipole moment of the molecules, but, as the high-pressure phase has longer hydrogen-bond distances, it is found that, on average, the hydrogen bonds in the ambient-pressure phase are stronger.
A cyclic complex [Ni(12)(chp)(12)(O(2)CMe)(12)(thf)(6)(H(2)O)(6)] (1) has been synthesised and studied (chp=6-chloro-2-pyridonate). Complex 1 exhibits ferromagnetic exchange between the S=1 centres, giving an S=12 spin ground state. Detailed studies demonstrate that it is a single-molecule magnet with an energy barrier of approximately 10 K for reorientation of magnetisation. Resonant quantum tunnelling is also observed. The field between resonances allows accurate measurement of D, which is 0.067 K. Inelastic neutron scattering studies have allowed exchange parameters to be derived accurately, which was impossible from susceptibility data alone. Three exchange interactions are required: two ferromagnetic nearest neighbour interactions of approximately 11 and 2 cm(-1) and an anti-ferromagnetic next nearest neighbour interaction of -0.9 cm(-1).
The reaction of [Mn3O(OAc)6(py)3] with 1,1,1-tris(hydroxymethyl)ethane (H3thme) gives the Mn(IV)3Mn(III)4Mn(II)2 complex [Mn9O7(OAc)11(thme)(py)3(H2O)2], which has an S = 17/2 ground state and displays strong out-of-phase signals in ac susceptibility studies that establish it as a new class of single-molecule magnet.
The synthesis, structural characterisation and preliminary magnetic studies of a Co12 wheel are reported; the magnetic investigations reveal that the electronic ground state has a spin S = 6, which corresponds to ferromagnetic interactions between the twelve Co(II) ions.
There is current interest in the antiviral activity of metal, especially zinc, cyclam (1,4,8,11-tetraazacyclotetradecane) complexes. Their biological activity appears to be dependent on recognition of membrane proteins (viral coreceptors) and therefore on their configurations. Here, we use Cd(II) as a probe for Zn(II) on account of its useful NMR properties. We have prepared and characterized Cd(II) complexes of cyclam, Cd(cyclam)(ClO(4))(2) (1), Cd(cyclam)Cl(2) (2), and [Cd(3)(cyclam)(3)(CO(3))](ClO(4))(4).3H(2)O (3), and have identified key markers for various configurations adopted by these complexes under a variety of solution conditions using 1D and 2D (1)H, (13)C, (15)N, and (111)Cd NMR spectroscopy, including Karplus-type analyses of (1)H, (1)H and (1)H, (111)Cd coupling constants. These complexes were stable at high pH (>8.2) but dissociated completely on lowering the pH to 5.3. Two major configurations of both 1 and 2 exist in aqueous solution: trans-I (R,S,R,S at nitrogen) and cis-V (R,R,R,R). (3)J((111)Cd, (1)H) coupling constants showed that the five-membered rings of the trans-I configuration adopt the eclipsed conformation, and the six-membered rings adopt chair conformations. The X-ray crystal structure of 3 shows that the cation adopts the unusual folded cis-I configuration in which all of the N-H bonds are oriented up (or down) in a novel tri-cadmium cluster. This complex contains triply bridged carbonate fixed from atmospheric CO(2). Each Cd(II) is bound by two cis oxygen atoms from CO(3)(2-) (Cd-O bond lengths 2.373 and 2.412 A) and four nitrogen atoms from cyclam (C-N bond lengths 2.270-2.323 A). The geometry can be described as trigonal bipyramidal with the two donor oxygen atoms occupying one of the apices of the in-plane triangle. In acetonitrile solution, complex 3 gives rise to only one configuration, trans-I, with eclipsed five-membered rings, and six-membered rings with chair conformations.
Explore the source record for details and available documents.
As platforms for the design of metal-based therapeutic and diagnostic agents, macrocycles are rigid enough to provide strong metal binding sites and orient functional groups stereoselectively, yet flexible enough to accommodate structural changes required for induced-fit recognition of biological targets. We consider the recognition of the Zn(II) complex of the bis-tetraazamacrocycle xylyl-bicyclam, a potent anti-HIV agent, by the coreceptor CXCR4, a G-protein-coupled receptor used by HIV for membrane fusion and cell entry. NMR studies show that the macrocycles of Zn(II)(2)-xylyl-bicyclam perchlorate exist in aqueous solution as two major configurations, trans-I (nitrogen chirality R,S,R,S), and trans-III (S,S,R,R). Acetate addition induced a major structural change. X-ray crystallography shows that the acetate complex contains the unusual cis-V cyclam configuration (R,R,R,R and folded) with bidentate coordination of acetate to Zn(II) plus second-coordination-sphere double H-bond formation between diagonal NH protons on the opposite cyclam face and acetate carboxylate oxygens. Detailed 1D and 2D NMR studies show that the major configuration of Zn(II)(2)-xylyl-bicyclam acetate in aqueous solution is cis-V/trans-I. Molecular modeling shows that an analogous cis-V site can be formed when Zn(II)(2)-xylyl-bicyclam binds to CXCR4, involving the carboxylate groups of Asp262 (Zn(II) coordination) and Glu288 (double H-bonding). The second cyclam can adopt the trans-I (or trans-III) configuration with Zn(II) binding to Asp171. These interactions are consistent with the known structure-activity relationships for bicyclam anti-HIV activity and receptor mutation. Consideration of the anti-HIV activity of xylyl-bicyclam complexes of other metal ions suggests that affinity for carboxylates, configurational flexibility, and kinetic factors may all play roles in receptor recognition. For example, Pd(II) cyclam complexes interact only weakly with axial ligands and are inflexible and inactive, whereas Co(III) cyclams bind carboxylates strongly, are configurationally flexible, and yet have low activity. Our findings should aid the design of new generations of active macrocycles including highly specific chemokine receptor antagonists.
The rational design of the organic ligand allows to finely tune the degree of delocalization of mixed-valence Prussian blue-like molecules.
Two new octanuclear cages are reported which feature formate as a bridging carboxylate which has been formed in situ from decomposition of triphenylacetate used as a ligand.
Organometallic ruthenium(II) arene anticancer complexes of the type [(eta(6)-arene)Ru(II)(en)Cl][PF(6)] (en = ethylenediamine) specifically target guanine bases of DNA oligomers and form monofunctional adducts (Morris, R., et al. J. Med. Chem. 2001). We have determined the structures of monofunctional adducts of the "piano-stool" complexes [(eta(6)-Bip)Ru(II)(en)Cl][PF(6)] (1, Bip = biphenyl), [(eta(6)-THA)Ru(II)(en)Cl][PF(6)] (2, THA = 5,8,9,10-tetrahydroanthracene), and [(eta(6)-DHA)Ru(II)(en)Cl][PF(6)] (3, DHA = 9,10-dihydroanthracene) with guanine derivatives, in the solid state by X-ray crystallography, and in solution using 2D [(1)H,(1)H] NOESY and [(1)H,(15)N] HSQC NMR methods. Strong pi-pi arene-nucleobase stacking is present in the crystal structures of [(eta(6)-C(14)H(14))Ru(en)(9EtG-N7)][PF(6)](2).(MeOH) (6) and [(eta(6)-C(14)H(12))Ru(en)(9EtG-N7)][PF(6)](2).2(MeOH) (7) (9EtG = 9-ethylguanine). The anthracene outer ring (C) stacks over the purine base at distances of 3.45 A for 6 and 3.31 A for 7, with dihedral angles of 3.3 degrees and 3.1 degrees, respectively. In the crystal structure of [(eta(6)-biphenyl)Ru(en)(9EtG-N7)][PF(6)](2).(MeOH) (4), there is intermolecular stacking between the pendant phenyl ring and the purine six-membered ring at a distance of 4.0 A (dihedral angle 4.5 degrees). This stacking stabilizes a cyclic tetramer structure in the unit cell. The guanosine (Guo) adduct [(eta(6)-biphenyl)Ru(en)(Guo-N7)][PF(6)](2).3.75(H(2)O) (5) exhibits intramolecular stacking of the pendant phenyl ring with the purine five-membered ring (3.8 A, 23.8 degrees) and intermolecular stacking of the purine six-membered ring with an adjacent pendant phenyl ring (4.2 A, 23.0 degrees). These occur alternately giving a columnar-type structure. A syn orientation of arene and purine is present in the crystal structures 5, 6, and 7, while the orientation is anti for 4. However, in solution, a syn orientation predominates for all the biphenyl adducts 4, 5, and the guanosine 5'-monophosphate (5'-GMP) adduct 8 [(eta(6)-biphenyl)Ru(II)(en)(5'-GMP-N7)], as revealed by NMR NOE studies. The predominance of the syn orientation both in the solid state and in solution can be attributed to hydrophobic interactions between the arene and purine rings. There are significant reorientations and conformational changes of the arene ligands in [(eta(6)-arene)Ru(II)(en)(G-N7)] complexes in the solid state, with respect to those of the parent chloro-complexes [(eta(6)-arene)Ru(II)(en)Cl](+). The arene ligands have flexibility through rotation around the arene-Ru pi-bonds, propeller twisting for Bip, and hinge-bending for THA and DHA. Thus propeller twisting of Bip decreases by ca. 10 degrees so as to maximize intra- or intermolecular stacking with the purine ring, and stacking of THA and DHA with the purine is optimized when their tricyclic ring systems are bent by ca. 30 degrees, which involves increased bending of THA and a flattening of DHA. This flexibility makes simultaneous arene-base stacking and N7-covalent binding compatible. Strong stereospecific intramolecular H-bonding between an en NH proton oriented away from the arene (en NH(d)) and the C6 carbonyl of G (G O6) is present in the crystal structures of 4, 5, 6, and 7 (average N...O distance 2.8 A, N-H...O angle 163 degrees ). NMR studies of the 5'-GMP adduct 8 provided evidence that en NH(d) protons are involved in strong H-bonding with the 5'-phosphate and O6 of 5'-GMP. The strong H-bonding from G O6 to en NH(d) protons partly accounts for the high preference for binding of [(eta(6)-arene)Ru(II)en](2+) to G versus A (adenine). These studies suggest that simultaneous covalent coordination, intercalation, and stereospecific H-bonding can be incorporated into Ru(II) arene complexes to optimize their DNA recognition behavior, and as potential drug design features.
This work reports the preparation and crystal structure of a trihydrate of paracetamol. Crystals were grown by slow cooling of an aqueous solution of paracetamol to 0 degrees C. Single-crystal X-ray diffraction shows that the trihydrate crystallizes in the orthorhombic crystal system, space group Pbca, Z = 8, a = 7.3324(16), b = 12.590(3), c = 22.636(6) A, V = 2089.7(9) A(3). The crystals of the trihydrate dehydrate rapidly at 20 degrees C to give anhydrous paracetamol as its monoclinic form.
We have synthesised the complex [Pt(CH(3)SCH(2)CH(2)SCH(3))(5'-GMP-N7)(2)].6H(2)O (1), where 5'-GMP is 5'-guanosine monophosphate, and determined its X-ray crystal structure. Pt(II) adopts a square-planar geometry in which the bases are coordinated head-to-tail (HT) in the Delta configuration. The nucleotide conformation in this complex is almost identical to that in the previously reported complex [Pt(en)(5'-GMP-N7)(2)].9H(2)O (2), in which there is outer sphere macrochelation via intramolecular H-bonding between the monoanionic phosphate groups and the coordinated ethylenediamine (en) NH. It is therefore apparent that intermolecular interactions rather than intramolecular H-bonding determines the orientation of the sugar-phosphate side-chain in these Pt(II) bisnucleotide complexes in the solid state.
Explore the source record for details and available documents.